At the 7th Top 100 Future Healthcare Conference in 2023 held on May 5, the list of the Top 100 companies was announced. Twenty-four companies from Beijing E-Town made the list, showcasing the vitality of high-quality development of the healthcare industry in the area.

The 7th Top 100 Future Healthcare Conference in 2023, held on May 5, names the top Chinese innovative healthcare enterprises that truly represent the future of the industry. [Photo/beijingetown.com.cn]

Future Healthcare Top 100 list is the first domestic innovative healthcare list for non-listed companies launched by VBData and VCBeat Research. The list has become one of the most authoritative references for evaluating healthcare companies, a bellwether of the development of the industry.

As a Contract Research Organization (CRO) specializing in innovative drug clinical research services, Guoxin Pharmaceutical focuses on providing one-stop clinical research services and overall solutions for innovative pharmaceutical companies worldwide. It has taken the lead in the fields of cell and gene therapy products, antibody-drug conjugates (ADCs), nucleic acid-based drugs, and more.

To date, Guoxin Pharmaceutical has participated in over 400 research and development projects, assisting numerous companies in successfully obtaining approvals for innovative drugs/generic drugs. It has also provided research and development services for various chemical drugs, innovative Chinese medicines, and medical devices. They have assisted dozens of companies in obtaining clinical approvals and supported their clinical research.

Union Strong Technology is a leading high-tech enterprise in China that focuses on intelligent diagnosis and treatment of acute and chronic cerebrovascular diseases. 

It aims to reconstruct the entire process of diagnosis and treatment for cerebrovascular diseases using intelligent means. 

The company's U-series products cover every stage of cerebrovascular disease, including prevention, screening, diagnosis, treatment, rehabilitation, and follow-up. It is a one-stop intelligent diagnosis and treatment platform for cerebrovascular diseases, a leader in the field in China.

In addition to the main list, the 2023 Future Healthcare Top 100 selection also includes the Innovation Power Ranking of Listed Companies, the Future Healthcare Top 100 Pengcheng Award, the Future Healthcare Top 100 Weilan Award, and the Future Healthcare Top 100 Value Field Award. Companies from Beijing E-Town have also made these lists.